Drug Type Synthetic peptide |
Synonyms KBP 336, KBP336 |
Target |
Mechanism CALCR inhibitors(Calcitonin receptor inhibitors), amylin inhibitors(Islet amyloid polypeptide inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | DK | 01 Feb 2024 | |
Obesity | Preclinical | CH | 01 Feb 2024 | |
Diabetes Mellitus, Type 1 | Preclinical | DK | 05 Sep 2023 | |
Diabetes Mellitus, Type 1 | Preclinical | CH | 05 Sep 2023 |